Thirumalai Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thirumalai Chemicals Limited reported its audited Q4 and FY25 results on May 16, 2025. On a standalone basis, revenue from operations grew ~8.3% to ₹215,207 lakhs and profit after tax surged ~126% to ₹8,221 lakhs (FY24: ₹3,630 lakhs), with basic EPS of ₹8.03. On a consolidated basis, the picture was weak — revenue declined ~1.6% to ₹204,951 lakhs and the company reported a net loss of ₹(4,610) lakhs, wider than the ₹(3,879) lakhs loss in FY24, along with negative operating cash flow of ₹(6,588) lakhs. The Board has decided not to recommend any dividend for FY25, citing the need to conserve funds for projects in advanced stages of execution. Statutory auditor Walker Chandiok & Co LLP issued an unmodified (clean) opinion on both standalone and consolidated results.
Strong standalone earnings and a clean audit opinion are positives, but consolidated losses, a skipped dividend, and sharply higher group-level borrowings (non-current borrowings up from ~₹81,253 lakhs to ~₹140,066 lakhs) to fund large capex (capital work-in-progress of ~₹135,211 lakhs) may keep sentiment cautious until subsidiary projects start contributing to profits.